These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 2629151)

  • 1. [Urinary enzymes as a marker of the preclinical stage of diabetic nephropathy].
    Dedov II; Mukhin NA; Pal'tsev MA; Delektorskaia LN; Shestakova MV
    Ter Arkh; 1989; 61(12):73-6. PubMed ID: 2629151
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Urinary enzymes in the assessment of the early stage of kidney involvement in psoriasis and diabetes mellitus].
    Golov KG; Varshavskiĭ VA; Okunev DIu; Neverov NI; Shestakova MV; Proskurneva FP
    Ter Arkh; 1995; 67(10):80-1. PubMed ID: 8779118
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical evaluation of N-acetyl-beta-D-glucosaminidase on prediction of diabetic nephropathy].
    Minakami H
    Hokkaido Igaku Zasshi; 1992 Mar; 67(2):234-46. PubMed ID: 1350771
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Urinary excretion of beta-thromboglobulin and N-acetyl-beta-D-glucosaminidase in type 1 diabetes: potential indicators of early nephropathy?
    Patrick AW; Oliver MD; Howie AF; Dawes J; Macintyre CC; Frier BM
    Diabete Metab; 1990; 16(5):441-7. PubMed ID: 2150050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Urine enzymes and low molecular weight proteins as indicators of diabetic nephropathy].
    Jung K; Pergande M; Schimke E; Ratzmann KP
    Klin Wochenschr; 1989; 67 Suppl 17():27-30. PubMed ID: 2739355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Urinary beta 2-microglobulin levels and urinary N-acetyl-beta-D-glucosaminidase enzyme activities in early diagnosis of non-insulin-dependent diabetes mellitus nephropathy.
    Mocan Z; Erem C; Yildirim M; Telatar M; Değer O
    Diabetes Res; 1994; 26(3):101-7. PubMed ID: 7621616
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The significance of urinary N-acetyl-beta-D-glucosaminidase for predicting early stage diabetic nephropathy.
    Kato H; Takashima T; Kishikawa H; Emura S; Ohmori K
    Int J Clin Pract; 1997; 51(8):489-90. PubMed ID: 9536599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Excretion of beta-N-acetylglucosaminidase in urine in type I and type II diabetic patients with and without nephropathy].
    Werle E; Bostedt A; Fiehn W; Hasslacher C
    Wien Klin Wochenschr Suppl; 1991; 189():59-62. PubMed ID: 1962487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Urinary activities of cathepsin B, N-acetyl-beta-D-glucosaminidase, and albuminuria in patients with type 2 diabetes mellitus.
    Piwowar A; Knapik-Kordecka M; Fus I; Warwas M
    Med Sci Monit; 2006 May; 12(5):CR210-4. PubMed ID: 16641878
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic significance of urinary transferrin in diabetic nephropathy.
    Kanauchi M; Nishioka H; Hashimoto T; Dohi K
    Nihon Jinzo Gakkai Shi; 1995 Nov; 37(11):649-54. PubMed ID: 8583702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pioglitazone reduces urinary protein and urinary transforming growth factor-beta excretion in patients with type 2 diabetes and overt nephropathy.
    Katavetin P; Eiam-Ong S; Suwanwalaikorn S
    J Med Assoc Thai; 2006 Feb; 89(2):170-7. PubMed ID: 16579002
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Urinary excretion of n-acetyl-beta-D-glucosaminidase and retinol binding protein as alternative indicators of nephropathy in patients with type 1 diabetes mellitus.
    Salem MA; el-Habashy SA; Saeid OM; el-Tawil MM; Tawfik PH
    Pediatr Diabetes; 2002 Mar; 3(1):37-41. PubMed ID: 15016173
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tubulopathy with macroalbuminuria due to diabetic nephropathy and primary glomerulonephritis.
    Yaqoob M; McClelland P; Patrick AW; Stevenson A; Mason H; Bell GM
    Kidney Int Suppl; 1994 Nov; 47():S101-4. PubMed ID: 7869656
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Urinary enzymes as markers of functional state of kidneys with diabetic lesions].
    Myhal' LIa; Korol' LV; Nikulina HH; Dudar IO; Zheltovs'ka NV
    Fiziol Zh (1994); 2006; 52(1):89-93. PubMed ID: 16553303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lessons learned from studies of the natural history of diabetic nephropathy in young type 1 diabetic patients.
    Steinke JM; Mauer M;
    Pediatr Endocrinol Rev; 2008 Aug; 5 Suppl 4():958-63. PubMed ID: 18806710
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of aerobic exercise on microalbuminuria and enzymuria in type 2 diabetic patients.
    Lazarevic G; Antic S; Vlahovic P; Djordjevic V; Zvezdanovic L; Stefanovic V
    Ren Fail; 2007; 29(2):199-205. PubMed ID: 17365936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary N-acetyl-beta-D-glucosaminidase activity in type I diabetes mellitus.
    Mungan N; Yuksel B; Bakman M; Topaloglu AK; Ozer G
    Indian Pediatr; 2003 May; 40(5):410-4. PubMed ID: 12768043
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Serum N-acetyl-beta-D-glucosaminidase (NAG) activity in patients with diabetes mellitus with reference to diabetic microangiopathy].
    Gosiewska A; Kinalska I; Zarzycki W; Górska M; Borejszo I
    Pol Tyg Lek; 1992 Jan 6-13; 47(1-2):28-30. PubMed ID: 1409037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic value of the aminopeptidase N, N-acetyl-beta-D-glucosaminidase and dipeptidylpeptidase IV in evaluating tubular dysfunction in patients with glomerulopathies.
    Mitic B; Lazarevic G; Vlahovic P; Rajic M; Stefanovic V
    Ren Fail; 2008; 30(9):896-903. PubMed ID: 18925530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural involvement in type 1 and type 2 diabetic nephropathy.
    Dalla Vestra M; Saller A; Bortoloso E; Mauer M; Fioretto P
    Diabetes Metab; 2000 Jul; 26 Suppl 4():8-14. PubMed ID: 10922968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.